Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines - PubMed (original) (raw)
- PMID: 6418375
Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines
C S Cooper et al. Cancer Res. 1984 Jan.
Abstract
Dominant transforming genes that were transferred to mouse NIH3T3 cells by cellular DNAs prepared from a chemically transformed human cell line (MNNG-HOS), a human teratocarcinoma cell line (PA1), and a human pancreatic carcinoma cell line (A1165) were characterized (a) analyzing the repetitive human DNA sequences that were associated with the transforming gene and (b) determining their relationship to the oncogenes of the Harvey (rasH) and Kirsten (rasK) sarcoma viruses and to the human neuroblastoma transforming gene (rasN). The results show that the transforming gene activated in the teratocarcinoma cell line is identical to the neuroblastoma transforming gene and that the transforming gene of the pancreatic carcinoma cell line is a human homologue of rasK. In contrast, the transforming gene activated in the chemically transformed human cell line showed no detectable homology to rasK, rasH, and rasN.
Similar articles
- Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
Blair DG, Cooper CS, Oskarsson MK, Eader LA, Vande Woude GF. Blair DG, et al. Prog Clin Biol Res. 1983;119:79-90. Prog Clin Biol Res. 1983. PMID: 6346333 - Mechanism of activation of human ras genes cloned from a gastric adenocarcinoma and a pancreatic carcinoma cell line.
O'Hara BM, Oskarsson M, Tainsky MA, Blair DG. O'Hara BM, et al. Cancer Res. 1986 Sep;46(9):4695-700. Cancer Res. 1986. PMID: 3731120 - Human oncogenes detected by a defined medium culture assay.
Zhan X, Culpepper A, Reddy M, Loveless J, Goldfarb M. Zhan X, et al. Oncogene. 1987;1(4):369-76. Oncogene. 1987. PMID: 3330780 - Neoplastic transformation of human cells in vitro.
Rhim JS. Rhim JS. Crit Rev Oncog. 1993;4(3):313-35. Crit Rev Oncog. 1993. PMID: 8485202 Review. - Transforming genes in human tumors.
Pulciani S, Santos E, Lauver AV, Long LK, Barbacid M. Pulciani S, et al. J Cell Biochem. 1982;20(1):51-61. doi: 10.1002/jcb.240200106. J Cell Biochem. 1982. PMID: 6761348 Review.
Cited by
- Activation of an N-ras gene in acute myeloblastic leukemia through somatic mutation in the first exon.
Gambke C, Hall A, Moroni C. Gambke C, et al. Proc Natl Acad Sci U S A. 1985 Feb;82(3):879-82. doi: 10.1073/pnas.82.3.879. Proc Natl Acad Sci U S A. 1985. PMID: 3856237 Free PMC article. - TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
Soman NR, Wogan GN, Rhim JS. Soman NR, et al. Proc Natl Acad Sci U S A. 1990 Jan;87(2):738-42. doi: 10.1073/pnas.87.2.738. Proc Natl Acad Sci U S A. 1990. PMID: 2300559 Free PMC article. - MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis.
Lu D, Nagelberg A, Chow JL, Chen YT, Michalchuk Q, Somwar R, Lockwood WW. Lu D, et al. Cancers (Basel). 2022 Mar 8;14(6):1378. doi: 10.3390/cancers14061378. Cancers (Basel). 2022. PMID: 35326531 Free PMC article. - The Role of PI3K in Met Driven Cancer: A Recap.
Hervieu A, Kermorgant S. Hervieu A, et al. Front Mol Biosci. 2018 Oct 24;5:86. doi: 10.3389/fmolb.2018.00086. eCollection 2018. Front Mol Biosci. 2018. PMID: 30406111 Free PMC article. Review. - Human recipient cell for oncogene transfection studies.
Tainsky MA, Shamanski FL, Blair D, Vande Woude G. Tainsky MA, et al. Mol Cell Biol. 1987 Mar;7(3):1280-4. doi: 10.1128/mcb.7.3.1280-1284.1987. Mol Cell Biol. 1987. PMID: 3470599 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical